PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method
暂无分享,去创建一个
Taesung Park | Seungyoon Nam | Sungyoung Lee | Sungjin Park | Jinhyuk Lee | Aron Park | Yon Hui Kim | Jinhyuk Lee | T. Park | S. Nam | Sungyoung Lee | Sungjin Park | Aron Park
[1] Matthew D Segall,et al. Multi-parameter optimization: identifying high quality compounds with a balance of properties. , 2012, Current pharmaceutical design.
[2] Diego di Bernardo,et al. Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis , 2014, Bioinform..
[3] T. Gilliam,et al. Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[5] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[6] T. Heskes,et al. The statistical properties of gene-set analysis , 2016, Nature Reviews Genetics.
[7] Yen‐Hua Huang,et al. Prioritizing disease candidate genes by a gene interconnectedness-based approach , 2011, BMC Genomics.
[8] Prashanth Athri,et al. Web-based drug repurposing tools: a survey , 2019, Briefings Bioinform..
[9] K. Kojima,et al. High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival , 2017, BMC Clinical Pathology.
[10] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[11] Carl Kingsford,et al. The power of protein interaction networks for associating genes with diseases , 2010, Bioinform..
[12] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[13] Riccardo Bellazzi,et al. Network-based target ranking for polypharmacological therapies , 2013, J. Biomed. Informatics.
[14] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[15] Silvio Bicciato,et al. GDA, a web-based tool for Genomics and Drugs integrated analysis , 2018, Nucleic Acids Res..
[16] Martin Lackmann,et al. Therapeutic targeting of EPH receptors and their ligands , 2013, Nature Reviews Drug Discovery.
[17] Jihye Kim,et al. DSigDB: drug signatures database for gene set analysis , 2015, Bioinform..
[18] Manolis Tsiknakis,et al. MinePath: Mining for Phenotype Differential Sub-paths in Molecular Pathways , 2016, PLoS Comput. Biol..
[19] S. Mori,et al. Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer , 2015, Molecular oncology.
[20] Q. Xue,et al. Dasatinib promotes TRAIL‐mediated apoptosis by upregulating CHOP‐dependent death receptor 5 in gastric cancer , 2018, FEBS open bio.
[21] Bing Zhang,et al. GLAD4U: deriving and prioritizing gene lists from PubMed literature , 2012, BMC Genomics.
[22] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[23] Maria Laura Bolognesi,et al. Harnessing Polypharmacology with Medicinal Chemistry. , 2019, ACS medicinal chemistry letters.
[24] Jae Yong Cho,et al. AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. , 2012, Cancer research.
[25] J. Werner,et al. A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.
[26] D. Richardson,et al. The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the "Triad of Death" in cancer by Di-2-pyridylketone thiosemicarbazones. , 2015, Pharmacological research.
[27] Russ B. Altman,et al. Pharmacogenomics and bioinformatics: PharmGKB. , 2010, Pharmacogenomics.
[28] Roded Sharan,et al. Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..
[29] C. Lipinski. Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.
[30] Marc Hafner,et al. L1000CDS2: LINCS L1000 characteristic direction signatures search engine , 2016, npj Systems Biology and Applications.
[31] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[32] Chao Wu,et al. Computational drug repositioning through heterogeneous network clustering , 2013, BMC Systems Biology.
[33] M. Vidal,et al. A genome-wide positioning systems network algorithm for in silico drug repurposing , 2019, Nature Communications.
[34] T Park,et al. PATHOME: an algorithm for accurately detecting differentially expressed subpathways , 2014, Oncogene.
[35] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[36] Alexander E. Ivliev,et al. Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach , 2013, PloS one.
[37] Angela N. Brooks,et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.
[38] Y. Li,et al. MicroRNA and signaling pathways in gastric cancer , 2014, Cancer Gene Therapy.
[39] David Botstein,et al. GO: : TermFinder--open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes , 2004, Bioinform..
[40] Marco Scutari,et al. Learning Bayesian Networks with the bnlearn R Package , 2009, 0908.3817.
[41] Taesung Park,et al. HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer , 2014, Gut.
[42] Jing Wang,et al. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit , 2017, Nucleic Acids Res..
[43] Xiang Zhang,et al. Drug repositioning by integrating target information through a heterogeneous network model , 2014, Bioinform..
[44] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[45] Armando Blanco,et al. DrugNet: Network-based drug-disease prioritization by integrating heterogeneous data , 2015, Artif. Intell. Medicine.
[46] E. Gallo,et al. Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics , 2020, Molecular Biology Reports.